Pet Genetic Testing Companies Are Making Promises They Can’t Keep
By Jessica Hekman,
Undark
| 09. 13. 2018
The promise of a sequenced genome is like a wrapped present, containing exactly what you always wanted but never knew you could get: predictions of all your future health problems and instructions for how to avoid them. Pet owners are the latest to fall prey to the myth of the “magic genome,” hoping that genetic testing will keep their animal companions alive and healthy for longer than ever before. The claims of many genetic testing companies encourage these unrealistic expectations.
The pet genetic testing industry has boomed in recent years as sequencing technology has improved and costs have plummeted. Several companies now tout direct-to-consumer tests that can screen companion animals, mostly dogs, for more than 150 genetic diseases including heart disease, kidney disease, and epilepsy. As a veterinarian and genomics researcher, I encounter dog owners who truly believe that genetic sequencing will save their animals’ lives.
What most pet genetic testing companies fail to make clear, though, is that genetic testing is riddled with uncertainty. Not all pets that test “clear” for a disease are truly safe from that condition...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...